People | February 23, 2022
Sumitomo Dainippon Pharma Oncology appoints Jatin J. Shah as Chief Medical Officer
Dr. Shah will lead strategic and operational clinical development of the company's diverse pipeline
Dr. Shah will lead strategic and operational clinical development of the company's diverse pipeline
DR devices today should do more than just provide crystal clear imaging and assist during diagnosis. Hence, the ImageView Software used in DRX Compass offers upgraded cybersecurity
Heterologous booster vaccination refers to the use of vaccine boosters from different technology platforms from the prime vaccines, which could improve the overall immune response and enhance protection against other variants
Phase 2 clinical trial to begin in 2022 with participation by Cedars Sinai Medical Center, University of Utah, and City of Hope
The newly enhanced drug development platform will help empower innovators with the fastest development timelines
Resolv ER may remedy leading causes of blindness in adults
Despite advances over the past 20 years, ovarian cancer treatment requires better standard of care
Collaboration aims to evolve precision medicine with cell-specific delivery of gene therapy
The device will facilitate the treatment of cerebral vasospasm following hemorrhagic stroke
TRIS AMINO HCl is widely used as a diagnostic reagent and as a downstream processing buffer in the purification of commercial biopharmaceuticals
Subscribe To Our Newsletter & Stay Updated
